[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Adenovirus Diagnostic Testing Market - Global Outlook and Forecast 2021-2027

April 2021 | 106 pages | ID: AB90AA3642D3EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Adenovirus Diagnostic Testing in Global, including the following market information:

Global Adenovirus Diagnostic Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Adenovirus Diagnostic Testing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adenovirus Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Adenovirus Diagnostic Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Adenovirus Diagnostic Testing Market Segment Percentages, By Type, 2020 (%)
  • Imaging Test
  • Respiratory Measurement
  • Bloodgas Test
  • Other
China Adenovirus Diagnostic Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Adenovirus Diagnostic Testing Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
Global Adenovirus Diagnostic Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Adenovirus Diagnostic Testing Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Adenovirus Diagnostic Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Adenovirus Diagnostic Testing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Abbott
  • Danaher
  • BioMerieux
  • Ortho Clinical Diagnostics
  • Roche
  • SiemensHealthineers
  • Tosoh
  • GSKBiologicals
  • ThermoFisher
  • Affymetrix
  • BectonDickinson
  • BioRad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Lonza
  • PerkinElmer
  • Qiagen
  • Scienion
  • Sequenom
  • SeraCare
  • Wako
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Adenovirus Diagnostic Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Adenovirus Diagnostic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADENOVIRUS DIAGNOSTIC TESTING OVERALL MARKET SIZE

2.1 Global Adenovirus Diagnostic Testing Market Size: 2021 VS 2027
2.2 Global Adenovirus Diagnostic Testing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Adenovirus Diagnostic Testing Players in Global Market
3.2 Top Global Adenovirus Diagnostic Testing Companies Ranked by Revenue
3.3 Global Adenovirus Diagnostic Testing Revenue by Companies
3.4 Top 3 and Top 5 Adenovirus Diagnostic Testing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Adenovirus Diagnostic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adenovirus Diagnostic Testing Players in Global Market
  3.6.1 List of Global Tier 1 Adenovirus Diagnostic Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Adenovirus Diagnostic Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Adenovirus Diagnostic Testing Market Size Markets, 2021 & 2027
  4.1.2 Imaging Test
  4.1.3 Respiratory Measurement
  4.1.4 Bloodgas Test
  4.1.5 Other
4.2 By Type - Global Adenovirus Diagnostic Testing Revenue & Forecasts
  4.2.1 By Type - Global Adenovirus Diagnostic Testing Revenue, 2016-2021
  4.2.2 By Type - Global Adenovirus Diagnostic Testing Revenue, 2022-2027
  4.2.3 By Type - Global Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Adenovirus Diagnostic Testing Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Diagnostic Centers
5.2 By Application - Global Adenovirus Diagnostic Testing Revenue & Forecasts
  5.2.1 By Application - Global Adenovirus Diagnostic Testing Revenue, 2016-2021
  5.2.2 By Application - Global Adenovirus Diagnostic Testing Revenue, 2022-2027
  5.2.3 By Application - Global Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Adenovirus Diagnostic Testing Market Size, 2021 & 2027
6.2 By Region - Global Adenovirus Diagnostic Testing Revenue & Forecasts
  6.2.1 By Region - Global Adenovirus Diagnostic Testing Revenue, 2016-2021
  6.2.2 By Region - Global Adenovirus Diagnostic Testing Revenue, 2022-2027
  6.2.3 By Region - Global Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Adenovirus Diagnostic Testing Revenue, 2016-2027
  6.3.2 US Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.3.3 Canada Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.3.4 Mexico Adenovirus Diagnostic Testing Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Adenovirus Diagnostic Testing Revenue, 2016-2027
  6.4.2 Germany Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.4.3 France Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.4.4 U.K. Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.4.5 Italy Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.4.6 Russia Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.4.7 Nordic Countries Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.4.8 Benelux Adenovirus Diagnostic Testing Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Adenovirus Diagnostic Testing Revenue, 2016-2027
  6.5.2 China Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.5.3 Japan Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.5.4 South Korea Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.5.5 Southeast Asia Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.5.6 India Adenovirus Diagnostic Testing Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Adenovirus Diagnostic Testing Revenue, 2016-2027
  6.6.2 Brazil Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.6.3 Argentina Adenovirus Diagnostic Testing Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Adenovirus Diagnostic Testing Revenue, 2016-2027
  6.7.2 Turkey Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.7.3 Israel Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.7.4 Saudi Arabia Adenovirus Diagnostic Testing Market Size, 2016-2027
  6.7.5 UAE Adenovirus Diagnostic Testing Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Adenovirus Diagnostic Testing Major Product Offerings
  7.1.4 Abbott Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.1.5 Abbott Key News
7.2 Danaher
  7.2.1 Danaher Corporate Summary
  7.2.2 Danaher Business Overview
  7.2.3 Danaher Adenovirus Diagnostic Testing Major Product Offerings
  7.2.4 Danaher Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.2.5 Danaher Key News
7.3 BioMerieux
  7.3.1 BioMerieux Corporate Summary
  7.3.2 BioMerieux Business Overview
  7.3.3 BioMerieux Adenovirus Diagnostic Testing Major Product Offerings
  7.3.4 BioMerieux Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.3.5 BioMerieux Key News
7.4 Ortho Clinical Diagnostics
  7.4.1 Ortho Clinical Diagnostics Corporate Summary
  7.4.2 Ortho Clinical Diagnostics Business Overview
  7.4.3 Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Major Product Offerings
  7.4.4 Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.4.5 Ortho Clinical Diagnostics Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Adenovirus Diagnostic Testing Major Product Offerings
  7.5.4 Roche Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.5.5 Roche Key News
7.6 SiemensHealthineers
  7.6.1 SiemensHealthineers Corporate Summary
  7.6.2 SiemensHealthineers Business Overview
  7.6.3 SiemensHealthineers Adenovirus Diagnostic Testing Major Product Offerings
  7.6.4 SiemensHealthineers Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.6.5 SiemensHealthineers Key News
7.7 Tosoh
  7.7.1 Tosoh Corporate Summary
  7.7.2 Tosoh Business Overview
  7.7.3 Tosoh Adenovirus Diagnostic Testing Major Product Offerings
  7.4.4 Tosoh Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.7.5 Tosoh Key News
7.8 GSKBiologicals
  7.8.1 GSKBiologicals Corporate Summary
  7.8.2 GSKBiologicals Business Overview
  7.8.3 GSKBiologicals Adenovirus Diagnostic Testing Major Product Offerings
  7.8.4 GSKBiologicals Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.8.5 GSKBiologicals Key News
7.9 ThermoFisher
  7.9.1 ThermoFisher Corporate Summary
  7.9.2 ThermoFisher Business Overview
  7.9.3 ThermoFisher Adenovirus Diagnostic Testing Major Product Offerings
  7.9.4 ThermoFisher Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.9.5 ThermoFisher Key News
7.10 Affymetrix
  7.10.1 Affymetrix Corporate Summary
  7.10.2 Affymetrix Business Overview
  7.10.3 Affymetrix Adenovirus Diagnostic Testing Major Product Offerings
  7.10.4 Affymetrix Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.10.5 Affymetrix Key News
7.11 BectonDickinson
  7.11.1 BectonDickinson Corporate Summary
  7.11.2 BectonDickinson Business Overview
  7.11.3 BectonDickinson Adenovirus Diagnostic Testing Major Product Offerings
  7.11.4 BectonDickinson Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.11.5 BectonDickinson Key News
7.12 BioRad
  7.12.1 BioRad Corporate Summary
  7.12.2 BioRad Business Overview
  7.12.3 BioRad Adenovirus Diagnostic Testing Major Product Offerings
  7.12.4 BioRad Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.12.5 BioRad Key News
7.13 Cepheid
  7.13.1 Cepheid Corporate Summary
  7.13.2 Cepheid Business Overview
  7.13.3 Cepheid Adenovirus Diagnostic Testing Major Product Offerings
  7.13.4 Cepheid Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.13.5 Cepheid Key News
7.14 Diamedix
  7.14.1 Diamedix Corporate Summary
  7.14.2 Diamedix Business Overview
  7.14.3 Diamedix Adenovirus Diagnostic Testing Major Product Offerings
  7.14.4 Diamedix Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.14.5 Diamedix Key News
7.15 DiaSorin
  7.15.1 DiaSorin Corporate Summary
  7.15.2 DiaSorin Business Overview
  7.15.3 DiaSorin Adenovirus Diagnostic Testing Major Product Offerings
  7.15.4 DiaSorin Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.15.5 DiaSorin Key News
7.16 Fujirebio
  7.16.1 Fujirebio Corporate Summary
  7.16.2 Fujirebio Business Overview
  7.16.3 Fujirebio Adenovirus Diagnostic Testing Major Product Offerings
  7.16.4 Fujirebio Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.16.5 Fujirebio Key News
7.17 Grifols
  7.17.1 Grifols Corporate Summary
  7.17.2 Grifols Business Overview
  7.17.3 Grifols Adenovirus Diagnostic Testing Major Product Offerings
  7.17.4 Grifols Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.17.5 Grifols Key News
7.18 Hologic
  7.18.1 Hologic Corporate Summary
  7.18.2 Hologic Business Overview
  7.18.3 Hologic Adenovirus Diagnostic Testing Major Product Offerings
  7.18.4 Hologic Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.18.5 Hologic Key News
7.19 Lonza
  7.19.1 Lonza Corporate Summary
  7.19.2 Lonza Business Overview
  7.19.3 Lonza Adenovirus Diagnostic Testing Major Product Offerings
  7.19.4 Lonza Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.19.5 Lonza Key News
7.20 PerkinElmer
  7.20.1 PerkinElmer Corporate Summary
  7.20.2 PerkinElmer Business Overview
  7.20.3 PerkinElmer Adenovirus Diagnostic Testing Major Product Offerings
  7.20.4 PerkinElmer Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.20.5 PerkinElmer Key News
7.21 Qiagen
  7.21.1 Qiagen Corporate Summary
  7.21.2 Qiagen Business Overview
  7.21.3 Qiagen Adenovirus Diagnostic Testing Major Product Offerings
  7.21.4 Qiagen Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.21.5 Qiagen Key News
7.22 Scienion
  7.22.1 Scienion Corporate Summary
  7.22.2 Scienion Business Overview
  7.22.3 Scienion Adenovirus Diagnostic Testing Major Product Offerings
  7.22.4 Scienion Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.22.5 Scienion Key News
7.23 Sequenom
  7.23.1 Sequenom Corporate Summary
  7.23.2 Sequenom Business Overview
  7.23.3 Sequenom Adenovirus Diagnostic Testing Major Product Offerings
  7.23.4 Sequenom Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.23.5 Sequenom Key News
7.24 SeraCare
  7.24.1 SeraCare Corporate Summary
  7.24.2 SeraCare Business Overview
  7.24.3 SeraCare Adenovirus Diagnostic Testing Major Product Offerings
  7.24.4 SeraCare Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.24.5 SeraCare Key News
7.25 Wako
  7.25.1 Wako Corporate Summary
  7.25.2 Wako Business Overview
  7.25.3 Wako Adenovirus Diagnostic Testing Major Product Offerings
  7.25.4 Wako Adenovirus Diagnostic Testing Revenue in Global (2016-2021)
  7.25.5 Wako Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Adenovirus Diagnostic Testing Market Opportunities & Trends in Global Market
Table 2. Adenovirus Diagnostic Testing Market Drivers in Global Market
Table 3. Adenovirus Diagnostic Testing Market Restraints in Global Market
Table 4. Key Players of Adenovirus Diagnostic Testing in Global Market
Table 5. Top Adenovirus Diagnostic Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Adenovirus Diagnostic Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Adenovirus Diagnostic Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Adenovirus Diagnostic Testing Product Type
Table 9. List of Global Tier 1 Adenovirus Diagnostic Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adenovirus Diagnostic Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Adenovirus Diagnostic Testing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Adenovirus Diagnostic Testing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Adenovirus Diagnostic Testing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Adenovirus Diagnostic Testing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Adenovirus Diagnostic Testing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Adenovirus Diagnostic Testing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Corporate Summary
Table 31. Abbott Adenovirus Diagnostic Testing Product Offerings
Table 32. Abbott Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 33. Danaher Corporate Summary
Table 34. Danaher Adenovirus Diagnostic Testing Product Offerings
Table 35. Danaher Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 36. BioMerieux Corporate Summary
Table 37. BioMerieux Adenovirus Diagnostic Testing Product Offerings
Table 38. BioMerieux Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 39. Ortho Clinical Diagnostics Corporate Summary
Table 40. Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Product Offerings
Table 41. Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 42. Roche Corporate Summary
Table 43. Roche Adenovirus Diagnostic Testing Product Offerings
Table 44. Roche Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 45. SiemensHealthineers Corporate Summary
Table 46. SiemensHealthineers Adenovirus Diagnostic Testing Product Offerings
Table 47. SiemensHealthineers Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 48. Tosoh Corporate Summary
Table 49. Tosoh Adenovirus Diagnostic Testing Product Offerings
Table 50. Tosoh Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 51. GSKBiologicals Corporate Summary
Table 52. GSKBiologicals Adenovirus Diagnostic Testing Product Offerings
Table 53. GSKBiologicals Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 54. ThermoFisher Corporate Summary
Table 55. ThermoFisher Adenovirus Diagnostic Testing Product Offerings
Table 56. ThermoFisher Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 57. Affymetrix Corporate Summary
Table 58. Affymetrix Adenovirus Diagnostic Testing Product Offerings
Table 59. Affymetrix Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 60. BectonDickinson Corporate Summary
Table 61. BectonDickinson Adenovirus Diagnostic Testing Product Offerings
Table 62. BectonDickinson Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 63. BioRad Corporate Summary
Table 64. BioRad Adenovirus Diagnostic Testing Product Offerings
Table 65. BioRad Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 66. Cepheid Corporate Summary
Table 67. Cepheid Adenovirus Diagnostic Testing Product Offerings
Table 68. Cepheid Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 69. Diamedix Corporate Summary
Table 70. Diamedix Adenovirus Diagnostic Testing Product Offerings
Table 71. Diamedix Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 72. DiaSorin Corporate Summary
Table 73. DiaSorin Adenovirus Diagnostic Testing Product Offerings
Table 74. DiaSorin Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 75. Fujirebio Corporate Summary
Table 76. Fujirebio Adenovirus Diagnostic Testing Product Offerings
Table 77. Fujirebio Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 78. Grifols Corporate Summary
Table 79. Grifols Adenovirus Diagnostic Testing Product Offerings
Table 80. Grifols Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 81. Hologic Corporate Summary
Table 82. Hologic Adenovirus Diagnostic Testing Product Offerings
Table 83. Hologic Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 84. Lonza Corporate Summary
Table 85. Lonza Adenovirus Diagnostic Testing Product Offerings
Table 86. Lonza Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 87. PerkinElmer Corporate Summary
Table 88. PerkinElmer Adenovirus Diagnostic Testing Product Offerings
Table 89. PerkinElmer Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 90. Qiagen Corporate Summary
Table 91. Qiagen Adenovirus Diagnostic Testing Product Offerings
Table 92. Qiagen Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 93. Scienion Corporate Summary
Table 94. Scienion Adenovirus Diagnostic Testing Product Offerings
Table 95. Scienion Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 96. Sequenom Corporate Summary
Table 97. Sequenom Adenovirus Diagnostic Testing Product Offerings
Table 98. Sequenom Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 99. SeraCare Corporate Summary
Table 100. SeraCare Adenovirus Diagnostic Testing Product Offerings
Table 101. SeraCare Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)
Table 102. Wako Corporate Summary
Table 103. Wako Adenovirus Diagnostic Testing Product Offerings
Table 104. Wako Adenovirus Diagnostic Testing Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Adenovirus Diagnostic Testing Segment by Type
Figure 2. Adenovirus Diagnostic Testing Segment by Application
Figure 3. Global Adenovirus Diagnostic Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Adenovirus Diagnostic Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Adenovirus Diagnostic Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adenovirus Diagnostic Testing Revenue in 2020
Figure 8. By Type - Global Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
Figure 12. US Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
Figure 16. Germany Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 17. France Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
Figure 24. China Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 28. India Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
Figure 30. Brazil Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Adenovirus Diagnostic Testing Revenue Market Share, 2016-2027
Figure 33. Turkey Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Adenovirus Diagnostic Testing Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Danaher Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. BioMerieux Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Roche Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. SiemensHealthineers Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Tosoh Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. GSKBiologicals Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. ThermoFisher Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Affymetrix Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. BectonDickinson Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. BioRad Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Cepheid Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Diamedix Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. DiaSorin Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Fujirebio Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Grifols Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Hologic Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Lonza Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. PerkinElmer Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Qiagen Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Scienion Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. Sequenom Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. SeraCare Adenovirus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications